跳至主要内容
临床试验/NCT03780192
NCT03780192Unknown不适用

INSPIRON Sirolimus Eluting Stent Performance in Bifurcation Coronary Arteries Treated Using Provisional Technique

Scitech Produtos Medicos Ltda1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2019年2月28日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
1
主要终点
Percentage of Stenosis

研究概览

简要总结

Evaluate the efficacy of the Inspiron Sirolimus Eluting Stent on bifurcation coronary artery lesions, in order to preserve and not compromize the side branch using the provisional stent technique.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with coronary artery disease on bifurcation anatomy with indication of drug eluting stent implantation , on which the side branch is ≥ 2.5 mm diameter and ostial stenosis ≤50% (Medina 1-1-0, 1-0-0, 0-1-0).

排除标准

  • Acute Myocardial Infarction (STMI);
  • Chronic occlusion;
  • Cardiogenic shock;
  • Ejection fraction ≤ 20%;
  • Thrombocytopenia (≤ 50 mil);
  • DAPT contraindication;
  • Life expectancy of less than 12 months.

结局指标

主要结局

Percentage of Stenosis

时间窗: day 0

% of stenosis on side branch after stent placement on main vessel

次要结局

未报告次要终点

研究者

发起方
Scitech Produtos Medicos Ltda
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Marco Vugman Wainstein

Principal Investigator Hospital Moinhos de Vento

Scitech Produtos Medicos Ltda

研究点 (1)

Loading locations...

相似试验